BIBO 3304 Trifluoroacetate

1 1

Selleck Chemicals

E0014-5MG

€321,00 EUR
€321,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
View full details

BIBO 3304 Trifluoroacetate is an antagonist of NPY1R used in studies of GPCR Signaling. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to receptor-driven second-messenger signaling and desensitization dynamics in neuroscience models.

By blocking NPY1R, BIBO 3304 Trifluoroacetate can be used to examine receptor-driven second-messenger signaling and desensitization dynamics. The gpcr annotation adds relevance to GPCR pharmacology, ligand-binding, and signaling assays, together with downstream-response mapping in the same experimental setting. In neuroscience models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving NPY1R
  • Pathway perturbation studies connected to GPCR Signaling
  • Receptor-blockade and ligand-competition studies
  • GPCR pharmacology, ligand-binding, and signaling assays

Overall, BIBO 3304 Trifluoroacetate is appropriate when a defined chemical perturbant is needed to connect NPY1R with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in neuroscience models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
NPY1R
Target Class:
GPCR
Pathways:
GPCR Signaling
Research Area:
Neuroscience
CAS No.:
191868-14-1
Molecular Weight:
643.66
Formula:
C₃₁H₃₆F₃N₇O₅
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.